WEBULL
News
ANPCY
0.154
-26.32%
-0.055
CelLBxHealth Showcases CTC Diagnostic Advances at World ADC Conference
Reuters · 11/05 07:00
BRIEF-Angle Appoints Peter Collins As Interim Chief Executive Officer
Reuters · 10/16 06:37
ANGLE plc Appoints Peter Collins as Interim CEO and Klaas de Boer as Senior Board Advisor
Reuters · 10/16 06:00
ANGLE plc to change name to CelLBxHealth plc
Reuters · 10/08 06:00
ANGLE plc Announces Breakthrough Clinical Study Demonstrating Parsortix System's Ability to Detect Circulating Tumor Cells in Glioblastoma Patients
Reuters · 09/29 06:00
Weekly Report: what happened at ANPCY last week (0908-0912)?
Weekly Report · 09/15 11:48
Angle PLC Announces Board Changes
Barchart · 09/11 21:30
ANGLE plc Reports Decline in Revenue and Increased Loss for H1 2025; EPS at (2.87) Pence
Reuters · 09/10 08:42
Weekly Report: what happened at ANPCY last week (0901-0905)?
Weekly Report · 09/08 11:50
Weekly Report: what happened at ANPCY last week (0825-0829)?
Weekly Report · 09/01 11:44
Weekly Report: what happened at ANPCY last week (0818-0822)?
Weekly Report · 08/25 11:58
ANGLE Partners With Myriad Genetics To Explore Extension Of Tissue-Based Companion Diagnostic Tests To Blood-Based CTC-DNA Testing
Benzinga · 08/20 07:37
Weekly Report: what happened at ANPCY last week (0811-0815)?
Weekly Report · 08/18 11:48
Weekly Report: what happened at ANPCY last week (0804-0808)?
Weekly Report · 08/11 11:57
Weekly Report: what happened at ANPCY last week (0728-0801)?
Weekly Report · 08/04 12:00
Weekly Report: what happened at ANPCY last week (0721-0725)?
Weekly Report · 07/28 12:01
Weekly Report: what happened at ANPCY last week (0714-0718)?
Weekly Report · 07/21 11:49
Weekly Report: what happened at ANPCY last week (0707-0711)?
Weekly Report · 07/14 12:01
Weekly Report: what happened at ANPCY last week (0630-0704)?
Weekly Report · 07/07 11:50
Weekly Report: what happened at ANPCY last week (0623-0627)?
Weekly Report · 06/30 11:58
More
Webull provides a variety of real-time ANPCY stock news. You can receive the latest news about CELLBXHEALTH PLC through multiple platforms. This information may help you make smarter investment decisions.
About ANPCY
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.